These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 8513541)
1. Theophylline in the ambulatory treatment of chronic obstructive lung disease: resolving a controversy. Snider GL Cleve Clin J Med; 1993; 60(3):197-201. PubMed ID: 8513541 [TBL] [Abstract][Full Text] [Related]
2. Bronchodilator effects of terbutaline and theophylline alone and in combination in patients with chronic obstructive lung disease. Baadsgaard O; Oberg B; Thomsen L; Klitgaard N; Simonsen E Allergol Immunopathol (Madr); 1985; 13(6):471-4. PubMed ID: 2870630 [TBL] [Abstract][Full Text] [Related]
3. Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. Tsukino M; Nishimura K; Ikeda A; Hajiro T; Koyama H; Izumi T Thorax; 1998 Apr; 53(4):269-73. PubMed ID: 9741369 [TBL] [Abstract][Full Text] [Related]
4. Theophylline in the treatment of the elderly with chronic obstructive pulmonary disease. Antognozzi G; Buzzo P; Mori M; Ellena S; Triolo A Riv Eur Sci Med Farmacol; 1994; 16(3-4):69-72. PubMed ID: 7480962 [TBL] [Abstract][Full Text] [Related]
5. Long acting beta(2) agonists and theophylline in stable chronic obstructive pulmonary disease. Cazzola M; Donner CF; Matera MG Thorax; 1999 Aug; 54(8):730-6. PubMed ID: 10413727 [No Abstract] [Full Text] [Related]
9. Is oral theophylline effective in combination with both inhaled anticholinergic agent and inhaled beta 2-agonist in the treatment of stable COPD? Nishimura K; Koyama H; Ikeda A; Izumi T Chest; 1993 Jul; 104(1):179-84. PubMed ID: 8325065 [TBL] [Abstract][Full Text] [Related]
10. [Theophylline and selective phosphodiesterase inhibitor in therapy of obstructive respiratory tract diseases]. Rabe KF; Dent G; Magnussen H Pneumologie; 1997 Mar; 51(3):303-16. PubMed ID: 9173421 [No Abstract] [Full Text] [Related]
12. Management of asthma and chronic airflow limitation. Are methylxanthines obsolete? Lam A; Newhouse MT Chest; 1990 Jul; 98(1):44-52. PubMed ID: 2193783 [TBL] [Abstract][Full Text] [Related]
13. Value of theophylline treatment in patients handicapped by chronic obstructive lung disease. McKay SE; Howie CA; Thomson AH; Whiting B; Addis GJ Thorax; 1993 Mar; 48(3):227-32. PubMed ID: 8497820 [TBL] [Abstract][Full Text] [Related]
14. Effects of theophylline and ipratropium on cognition in elderly patients with chronic obstructive pulmonary disease. Ramsdell JW; Henderson S; Renvall MJ; Salmon DP; Ferguson P Ann Allergy Asthma Immunol; 1996 Apr; 76(4):335-40. PubMed ID: 8612115 [TBL] [Abstract][Full Text] [Related]
15. Salmeterol versus slow-release theophylline in patients with reversible obstructive pulmonary disease. Taccola M; Bancalari L; Ghignoni G; Paggiaro PL Monaldi Arch Chest Dis; 1999 Aug; 54(4):302-6. PubMed ID: 10546469 [TBL] [Abstract][Full Text] [Related]
16. Comparative studies of atropine methonitrate and its combination with reproterol in chronic airway obstruction. Macha HN; Aurich R Arzneimittelforschung; 1982; 32(7):774-6. PubMed ID: 6751338 [TBL] [Abstract][Full Text] [Related]